Gao, IL
Danchen Gao, Long Grove, IL US
Patent application number | Description | Published |
---|---|---|
20100104651 | Pharmaceutical Compositions Containing Diacerein - A once-daily controlled-release formulation of diacerein for treating inflammatory or autoimmune diseases or their complications, with reduced adverse side effects and methods of treating such diseases are disclosed. | 04-29-2010 |
20110045522 | METHODS FOR DIAGNOSING DIABETES AND DETERMINING EFFECTIVENESS OF TREATMENTS - The invention generally relates to novel methods of measuring the effectiveness of a drug for the treatment of diabetes and methods of diagnosing diabetes. In some embodiments of the invention, IL-1Ra is used as a biomarker to measure the effectiveness of a drug for the treatment of diabetes. | 02-24-2011 |
20110251155 | Methods of Using Diacerein as an Adjunctive Therapy for Diabetes - The present invention provides methods of treating type II diabetes using combinations of diacerein or its derivatives with other antidiabetic agents. The methods may also allow improving glycemic control of type II diabetes patients and/or reducing side effects and/or cardiovascular risks of antidiabetic agents. | 10-13-2011 |
20130156857 | Pharmaceutical Compositions Containing Diacerein - A once-daily controlled-release formulation of diacerein for treating inflammatory or autoimmune diseases or their complications, with reduced adverse side effects and methods of treating such diseases are disclosed. | 06-20-2013 |
Danchen Gao, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20120171284 | CELECOXIB COMPOSITIONS - Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising particulate celecoxib in an amount of about 10 mg to about 1000 mg in intimate mixture with one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders. | 07-05-2012 |
Feng (frank) Gao, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20110255666 | SYSTEM AND METHOD FOR MONITORING X-RAYS RECEIVED BY A PORTABLE IMAGING DETECTOR - A method for imaging an object includes radiating the object of interest and sensing the radiation that penetrates through the object using a detector having at least one active area and at least one inactive area, determining when the radiation is completed using information received from the inactive area of the imaging detector, and reconstructing an image of the object using information received from the active area of the imaging detector. A medical imaging system and a computer-readable medium are also provided. | 10-20-2011 |
Frank Gao, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20090039278 | SYSTEMS, METHODS AND APPARATUS FOR CORRECTION OF FIELD-EFFECT TRANSISTOR LEAKAGE IN A DIGITAL X-RAY DETECTOR - Systems, methods and apparatus are provided through which in some embodiments field-effect-transistor (FET) leakage is estimated recursively from a pixel value obtained when the FET is off. The corrected pixel value is then obtained by subtracting the FET leakage estimate from the pixel value read when the FET is on. A weighing factor is introduced for the FET leakage estimation to achieve the balance between image noise and correction resolution. | 02-12-2009 |
Hongyu Gao, Evanston, IL US
Patent application number | Description | Published |
---|---|---|
20130151429 | SYSTEM AND METHOD OF DETERMINING ENTERPRISE SOCIAL NETWORK USAGE - According to an embodiment, a computing system includes at least one computing device including a processor configured to use a logistic regression model to provide an indication of a relationship between a user's position within an enterprise and how the user interacts with other users of an enterprise social network. | 06-13-2013 |
Jia-Hong Gao, Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20110013138 | Vision Treatment Procedures and Devices - A vision treatment system comprises a computer and a user input output module associated with the computer, the user input output module including a display screen and means for receiving user input, wherein the computer includes a testing and training module for one or more vision disorders, the training and testing module in communication with the user input output module and testing a user's cutoff spatial frequency of a contrast sensitivity and applying a training regimen based upon Perceptual Template Model (PTM) analysis of interactions with the user. | 01-20-2011 |
Jing Gao, Urbana, IL US
Patent application number | Description | Published |
---|---|---|
20130346411 | IDENTIFYING INCONSISTENCIES IN OBJECT SIMILARITIES FROM MULTIPLE INFORMATION SOURCES - A horizontal anomaly detection method includes receiving at plurality of objects described in a plurality of information sources, wherein each individual information source captures a plurality of similarity relationships between the objects, combining the information sources to determine a similarity matrix whose entries represent quantitative scores of similarity between pairs of the objects, and identifying at least one horizontal anomaly of the objects within the similarity matrix, wherein the horizontal anomalies are anomalous relationships across the plurality of information sources. | 12-26-2013 |
Ju Gao, Champaign, IL US
Patent application number | Description | Published |
---|---|---|
20090128031 | AC, RF or pulse excited microdischarge device and array - An AC, rf, or pulse-excited microdischarge device and array are provide by the invention. A preferred array includes a substrate. A plurality of microdischarge cavities that contain discharge medium are in the substrate. A transparent layer seals the discharge medium in the microdischarge cavites. Electrodes stimulate the discharge medium. The microdischarge cavities are physically isolated from the electrodes by dielectric and arranged relative to the electrodes such that ac, rf, or pulsed excitation applied to the electrodes stimulates plasma excitation of the discharge medium. The microdischarge cavities are sized to produce plasma within the microdischarge cavities. | 05-21-2009 |
20090180735 | Integrated light source and optical waveguide and method - An optical system and method including an integrated light source and optical waveguide that relies on internal reflection for coupling the light emitted from the source to the waveguide. The light source may include electroded or electrodeless plasma lamps, LEDs, and filament lamps. The optical waveguide may be shaped to form a compound parabolic waveguide. A system may also include an integrated light source, microwave waveguide, and optical coupler. | 07-16-2009 |
20100301730 | HIGH INTENSITY DISCHARGE ARC LAMP USING UV-ABSORBANT COATING - A high intensity discharge arc lamp comprises an arc tube, a metal halide in the arc tube, and a coating on the arc tube. The coating comprises a UV absorbent material. | 12-02-2010 |
Ju Gao, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20140369034 | LIGHT-EMITTING DIODE (LED) LAMP FOR EMITTING LIGHT IN NEARLY ALL DIRECTIONS - A light-emitting diode lamp for emitting light in nearly all directions has a lamp holder, an LED power supply, a cylindrical surface-mounted device (SMD) LED light source, a lamp shade, a metal connecting piece, a metal radiator and a flame-retardant plastic connecting piece. The LED light source is fixed in the flame-retardant plastic connecting piece; an upper portion of the flame-retardant plastic connecting piece is mechanically fixed with the lamp holder and a lower portion is mechanically fixed with the lamp shade through the metal radiator; one end of the metal connecting piece is fixed with the metal radiator and the other end is extended into the lamp shade; the cylindrical SMD LED light source is adhered to an outer side surface of a portion of the metal connecting piece extended into the lamp shade; and the lamp holder. | 12-18-2014 |
Mingshen Gao, Batavia, IL US
Patent application number | Description | Published |
---|---|---|
20090144740 | Application-based enhancement to inter-user priority services for public safety market - A system and method for application based enhancement to the traditional per-user based inter-user priority services is provided. This method includes provisioning a user's profile, not only with an assigned inter-user priority, but also with zero, one or more specified and provisioned applications that are considered as critical applications which require special preferential treatment by the access network. The method continues with accessing the inter-user priority profile associated for sessions established for the user. The system then recognizes that a session may have been assigned to at least one provisioned critical application. The system may then provide inter-user priority services operative to provide the specified preferential treatment for at least the critical applications associated with the session when the critical application(s) are activated. In this form, the critical applications are better served including protection again congestion and availability of resources whenever they are needed. This system may grant preferential treatment on a session and/or application basis so that there will be no impact on other general applications when no critical applications are activated. This is especially useful for public safety implementation where protecting the mission-critical communication is a fundamental requirement. | 06-04-2009 |
20100128646 | Fast signaling services for E-UTRAN based wireless systems - Fast Signaling Services (FSS) for E-UTRAN based wireless systems are provided. A mobility management entity defines FSS MBSFN areas for its tracking areas and generates a FSS packet including signaling information intended for a plurality of UEs in a tracking area of the wireless network. The tracking area and its associated FSS MBSFN area includes a plurality of cells/eNodeBs. The mobility management entity multicasts the generated packet to the plurality of cells/eNodeBs in the FSS MBSFN area that covers the tracking area. The plurality of eNodeBs broadcast the packaged signaling messages to the plurality of UEs in the tracking area using the FSS MBSFN transmission. The FSS improves signaling performance of the overall system for the E-UTRAN. | 05-27-2010 |
20100173636 | Method for improving frequency reuse utilizing synchronized downlink resources from adjacent cells - The present invention provides a method for improving frequency reuse utilizing synchronized downlink resources from adjacent cells. The communication system determines that a mobile unit is receiving signals from a first cell and one or more adjacent cells. Upon receiving the data from the EPC to be sent to the mobile unit, the data is also sent to the adjacent cells from the serving cell via the X2-interface by embedding SYNC information into the GTP-U for carrying the PDUs if the adjacent cells are hosted by different eNodeBs. The first cell and adjacent cells allocate identical downlink resource blocks. The first cell and adjacent cells concurrently transmit the data to be received by user equipment within the communication system. | 07-08-2010 |
20100197323 | Proactive menu-driven links or triggers for location-based services and mobile advertising - Example embodiments provides low-cost, effective methods of mobile advertising to mobile users. The methods provide both transmitting and receiving broadcast text-formatted, category-based data relating to services from local businesses and on-demand services, to capable mobile devices in a zone formed by network nodes, without user interaction. The data may be viewed as lists with menu-driven ‘contact-list’ type software, familiar to most mobile device users and configurable by nearly all types of mobile devices. The methods also notify a user of a mobile device when new events occur or service information is updated. Example embodiments use the broadcast-multicast capability of Radio Access Networks (RAN) to transmit to mobile devices served by sectors or cells in a localized zone (e.g., one or more cells that cover a shopping mall and nearby areas). | 08-05-2010 |
Ping Gao, Highland Park, IL US
Patent application number | Description | Published |
---|---|---|
20140113921 | FORMULATIONS OF PYRIMIDINEDIONE DERIVATIVE COMPOUNDS - The present disclosure relates to pharmaceutical compositions of pyrimidinedione derivative compounds and methods of preparing and uses thereof. The disclosure also relates to methods of enhancing bioavailability of pyrimidinedione derivative compounds in pharmaceutical compositions administered to a subject and methods of reducing the amount of a pyrimidinedione derivative compound in a pharmaceutical composition while achieving the same bioavailability in a subject. | 04-24-2014 |
Ping X. Gao, Highland Park, IL US
Patent application number | Description | Published |
---|---|---|
20150258093 | SOLID ANTIVIRAL DOSAGE FORMS - The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection. | 09-17-2015 |
Qingshen Gao, Lake Forest, IL US
Patent application number | Description | Published |
---|---|---|
20090137479 | METHODS OF TREATING AND DIAGNOSING LAMINOPATHY - The invention provides a method of treating laminopathy in a subject comprising administering a therapeutically effective amount of centrobin polypeptide to the subject such that laminopathy is treated. The invention also provides a method of identifying an agent that enhances nuclear envelope integrity. The method comprises administering an agent to a cell comprising mutant centrobin, allowing the cell to replicate to form daughter cells, and observing nuclear envelope morphology within the daughter cells. In addition, the invention includes a method for diagnosing or identifying a predisposition to a laminopathy. The method comprises detecting the presence or absence of mutant centrobin in a sample, wherein the presence of mutant centrobin indicates that the subject is suffering from, or is predisposed to develop, a laminopathy. A kit for diagnosing or identifying a predisposition to a laminopathy also is provided. | 05-28-2009 |
20110086042 | Centrosomal Proteins, Nucleic Acids and Method of Use Thereof - The present invention provides novel isolated centrobin polynucleotides and polypeptides encoded by the centrobin polynucleotides. The invention additionally provides methods of inhibiting cell growth by contacting a cell with a centrobin inhibitor. | 04-14-2011 |
Xiuzhi Gao, Mount Prospect, IL US
Patent application number | Description | Published |
---|---|---|
20130067409 | Customizable Database-Driven Menu Structure for a Portable Computing Device - A portable media playing device incorporating a menu structure. The device includes a display mechanism, a navigation database, including a navigation record with a navigation description, and an action database, including an action record with an action description. The action database is customizable. A display driver displays the navigation description. When the navigation description is selected, the display driver displays the action description. When the action description is selected, a digital synchronization system generates an extra action request (EAR) record that includes an action identifier and action data for storage in an EAR database. When the device is synchronized with a computer, a synchronization manager accesses the EAR database and updates the action database with any new action records. | 03-14-2013 |
20130188960 | One-Handed Remote Unit That Can Control Multiple Devices - A universal console using infra-red (IR) technology allows users to consolidate their remote control devices to a single universal device that can control a PC, DVD, games, TV, and other IR coupled devices. It further has the benefit of being highly power efficient and thus allowing the use of batteries without needed to be recharged or replaced for many months. Through the use of different dongles (and different configurations) different models can be offered for use on game consoles, smart TVs, and other connected devices. | 07-25-2013 |
Xiuzhi Gao, Elgin, IL US
Patent application number | Description | Published |
---|---|---|
20150137956 | One-handed remote unit that can control multiple devices - A universal console using infra-red (IR) technology allows users to consolidate their remote control devices to a single universal device that can control a PC, DVD, games, TV, and other IR coupled devices. It further has the benefit of being highly power efficient and thus allowing the use of batteries without needed to be recharged or replaced for many months. Through the use of different dongles (and different configurations) different models can be offered for use on game consoles, smart TVs, and other connected devices. | 05-21-2015 |
Yi Gao, Vernon Hills, IL US
Patent application number | Description | Published |
---|---|---|
20090176784 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 07-09-2009 |
20090186912 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 07-23-2009 |
20090263477 | SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF - In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients. | 10-22-2009 |
20100310607 | PHARMACEUTICAL FORMULATIONS - The present invention relates to oral formulations comprising an active agent comprising at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, salts of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid or buffered 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid. | 12-09-2010 |
20110237675 | PHARMACEUTICAL FORMULATIONS - The present invention provides a modified release formulation comprising an active agent in a hydrophilic polymer matrix wherein the active agent is a salt of fenofibric acid wherein the release rate of the formulation in an in vitro dissolution is substantially independent of the ionic strength of the dissolution media. | 09-29-2011 |
20110306632 | Solid Dispersions Containing Kinase Inhibitors - A solid dispersion comprises, in essentially non-crystalline form, a kinase inhibitory compound, e.g., N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N′-(3-fluorophenyl)urea, dispersed in a solid matrix that comprises (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. A process for preparing such a solid dispersion comprises dissolving the compound, the polymeric carrier and the surfactant in a suitable solvent, and removing the solvent to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. The solid dispersion is suitable for oral administration to a subject in need thereof for treatment of a cancer. | 12-15-2011 |
20120004196 | Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. | 01-05-2012 |
20120171262 | PHARMACEUTICAL FORMULATIONS - The present invention relates to oral formulations comprising an active agent comprising at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, salts of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid or buffered 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid. | 07-05-2012 |
20120189580 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 07-26-2012 |
20120220562 | Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. | 08-30-2012 |
20120244119 | ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 09-27-2012 |
20120258909 | Solid Compositions - The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant. | 10-11-2012 |
20120264780 | SOLID COMPOSITIONS - The present invention features solid compositions comprising Compound I | 10-18-2012 |
20130018101 | SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF - In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients. | 01-17-2013 |
20130078284 | PHARMACEUTICAL FORMULATIONS - The present invention relates to oral formulations comprising an active agent comprising at least one of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid, salts of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid or buffered 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid. | 03-28-2013 |
20130085181 | PHARMACEUTICAL FORMULATIONS - The present invention provides a modified release formulation comprising an active agent in a hydrophilic polymer matrix wherein the active agent is a salt of fenofibric acid wherein the release rate of the formulation in an in vitro dissolution is substantially independent of the ionic strength of the dissolution media. | 04-04-2013 |
20130172239 | SOLID COMPOSITIONS - The present invention features solid compositions comprising a selected HCV inhibitor in an amorphous form. In one embodiment, the selected HCV inhibitor is formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant. | 07-04-2013 |
20140113921 | FORMULATIONS OF PYRIMIDINEDIONE DERIVATIVE COMPOUNDS - The present disclosure relates to pharmaceutical compositions of pyrimidinedione derivative compounds and methods of preparing and uses thereof. The disclosure also relates to methods of enhancing bioavailability of pyrimidinedione derivative compounds in pharmaceutical compositions administered to a subject and methods of reducing the amount of a pyrimidinedione derivative compound in a pharmaceutical composition while achieving the same bioavailability in a subject. | 04-24-2014 |
20140171481 | SOLID COMPOSITIONS - The present invention features solid compositions comprising amorphous Compound I. For instance, Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant. | 06-19-2014 |
20140187561 | SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF - In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients. | 07-03-2014 |
20140294766 | Anti-Infective Agents and Uses Thereof - This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. | 10-02-2014 |
20140315792 | ANTI-VIRAL COMPOUNDS - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. | 10-23-2014 |
20150025024 | Solid Compositions - The present invention features solid compositions comprising a selected HCV inhibitor in an amorphous form. In one embodiment, the selected HCV inhibitor is formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant. | 01-22-2015 |
20150087618 | Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. | 03-26-2015 |
20150218194 | Anti-Viral Compounds - Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection. | 08-06-2015 |
20150258093 | SOLID ANTIVIRAL DOSAGE FORMS - The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection. | 09-17-2015 |
Yong Gao, Carbdondale, IL US
Patent application number | Description | Published |
---|---|---|
20100130763 | PROCESSES FOR THE PRODUCTION OF FATTY ACID ALKYL ESTERS - The present invention provides processes for the formation of fatty acid alkyl esters, which may be used as biodiesel. In particular, the invention provides an esterification process in which a lipid material is contacted with an alcohol in the presence of a metal halide or metal alkoxide conjugated to a solid support. Also provided is a transesterification process in which a lipid material is contacted with an alcohol in the presence of an N-heterocyclic carbene. Also provided is a combination esterification and transesterification process in which a lipid material is contacted with a metal halide or metal alkoxide conjugated to a solid support, and then is contacted with an N-heterocyclic carbene or an alkaline catalyst. | 05-27-2010 |
Yong Gao, Carbondale, IL US
Patent application number | Description | Published |
---|---|---|
20080289248 | IMMOBILIZED ESTERIFICATION CATALYSTS FOR PRODUCING FATTY ACID ALKYL ESTERS - Provided herein are processes for the production of biodiesel. In particular, provided is an esterification process in which an alcohol reacts with free fatty acids in a lipid material comprising free fatty acids and glycerides in the presence of an immobilized zirconium(IV) metal salt to form fatty acid alkyl esters. Also provided is combination process in which an esterification reaction converts the free fatty acids in a lipid material to fatty acid alkyl esters and a transesterification reaction converts the glycerides in the material to fatty acid alkyl esters. | 11-27-2008 |
20110190506 | NANO-REAGENTS WITH COOPERATIVE CATALYSIS AND THEIR USES IN MULTIPLE PHASE REACTIONS - Nano-reagents with catalytic activity are provided herein. The nanocatalyst comprises at least one amino acid attached to a nanoparticle, wherein the reactive side chain of the amino acid catalyzes a chemical or biological reaction. Methods of using these nano-reagents to catalyze reactions in solution or in multiple phases are also provided, as are methods of making these nanocatalysts. | 08-04-2011 |
20140127138 | PH-SENSITIVE IMAGING AGENTS - Composition and method for surface-functionalized SPION-based agents. Such agents can provide highly pH-sensitive MRI contrast in tissue. | 05-08-2014 |
Zhan Gao, Evanston, IL US
Patent application number | Description | Published |
---|---|---|
20150147677 | FABRICATION OF SOLID OXIDE FUEL CELLS WITH A THIN (LA0.9SR0.1)0.98(GA0.8MG0.2)O3-delta ELECTROLYTE ON A SR0.8LA0.2TIO3 SUPPORT - Methods and compositions for a low temperature operating solid oxide fuel cell (SOFC) are provided. The SOFC includes a Sr | 05-28-2015 |